Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
CureVac N.V. - Ordinary Shares
(NQ:
CVAC
)
4.660
UNCHANGED
Last Price
Updated: 4:00 PM EST, Jan 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about CureVac N.V. - Ordinary Shares
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Why CureVac Stock Leaped 12% Higher Today
↗
June 20, 2023
The war on cancer advances with the German company's latest clinical development.
Via
The Motley Fool
DICE Therapeutics, Surmodics, Nikola, And Other Big Stocks Moving Higher On Tuesday
↗
June 20, 2023
U.S. stocks traded lower, with the Dow Jones dropping around 250 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
CureVac Doses First Patient in Phase 1 Study of Cancer Vaccine Candidate for Surgically Resected Glioblastoma
June 20, 2023
Via
ACCESSWIRE
CureVac Appoints International Financial Expert Michael Brosnan to Supervisory Board
June 20, 2023
Via
ACCESSWIRE
Earnings Preview: CureVac
↗
April 24, 2023
Via
Benzinga
CureVac Announces Voting Results of General Meeting
June 19, 2023
Via
ACCESSWIRE
Benzinga's Top Ratings Upgrades, Downgrades For June 8, 2023
↗
June 08, 2023
Via
Benzinga
CureVac Announces Financial Results for the First Quarter of 2023 and Provides Business Update
May 30, 2023
Via
ACCESSWIRE
Why CohBar Shares Are Trading Lower By 161%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
May 23, 2023
Gainers
Via
Benzinga
CureVac Announces Developments in Patent Litigation with Pfizer/BioNTech
May 19, 2023
Via
ACCESSWIRE
CureVac Announces Dosing of First Participant in Combined Phase 1/2 Study of Multivalent, Modified Influenza Vaccine Candidates Developed in Collaboration with GSK
May 08, 2023
Via
ACCESSWIRE
CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2022 and Provides Business Update
April 25, 2023
Via
ACCESSWIRE
CureVac to Report Fourth Quarter and Full-Year 2022 Financial Results and Business Updates on April 25, 2023
April 18, 2023
Via
ACCESSWIRE
CureVac Announces Voting Results of Extraordinary General Meeting
March 28, 2023
Via
ACCESSWIRE
Moderna Hypes 'Important Step' In Flu Shot Results, But Market Disagrees
↗
February 17, 2023
Shares crumbled after Moderna's flu shot outperformed in just one flu strain.
Via
Investor's Business Daily
Pfizer/BioNTech Get Ready For London Court Battle With Moderna Over COVID-19 Vaccine Patents
↗
February 17, 2023
Via
Benzinga
CureVac Announces Closing of $250 million Follow-on Public Offering of Common Shares
February 10, 2023
Via
ACCESSWIRE
Why CureVac Shares Are Nosediving Today
↗
February 07, 2023
CureVac BV (NASDAQ: CVAC) shares are trading lower by 13.99% to $9.10 during Tuesday's session after the company announced a proposed public offering of common stock. What Happened?
Via
Benzinga
Why Bed Bath & Beyond Fell Almost 30%; Here Are 20 Stocks Moving Premarket
↗
February 07, 2023
Gainers
Via
Benzinga
CureVac Announces Proposed Public Offering of Common Shares
February 07, 2023
Via
ACCESSWIRE
CureVac Welcomes Myriam Mendila as New Chief Development Officer
February 01, 2023
Via
ACCESSWIRE
CureVac Named as One of the World’s Most Dynamic Innovators by LexisNexis(R)
January 31, 2023
Via
ACCESSWIRE
CureVac Shares Pop After Encouraging Update From COVID-19, Flu mRNA Vaccine Programs
↗
January 30, 2023
Via
Benzinga
CureVac Announces Positive Data in Older Adults from COVID-19 and Flu mRNA Vaccine Development Programs
January 30, 2023
Via
ACCESSWIRE
The 3 Best Biotech Stocks Under $1 to Buy for January
↗
January 26, 2023
Even the best small biotech stocks can go bust on a single bad study, but the winners can make their early investors rich.
Via
InvestorPlace
Why Jupiter Wellness Shares Are Trading Lower By Around 40%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
January 19, 2023
Gainers Genius Group Limited (NYSE: GNS) jumped 87% to $1.00. Genius Group authorized issue of special dividend and appointed Timothy Murphy to lead Illegal Trading Task Force.
Via
Benzinga
Concert Pharmaceuticals, Coeur Mining And Other Big Stocks Moving Higher On Thursday
↗
January 19, 2023
U.S. stocks traded lower, with the Dow Jones dropping around 200 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2023
↗
January 19, 2023
Via
Benzinga
Why Starbox Group Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket
↗
January 19, 2023
Gainers Tricida, Inc. (NASDAQ: TCDA) rose 37.7% to $0.1898 in pre-market trading after gaining 4% on Wednesday.
Via
Benzinga
Nasdaq, S&P 500 Futures Slump Ahead Of Netflix Earnings, Another Batch Of Economic Data
↗
January 19, 2023
The index futures point to a moderately lower opening for Wall Street stocks on Thursday, as the negative sentiment carries over into the new trading day.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
